HALSA CARE GROUP LIMITED

HALSA CARE GROUP LIMITED

HCG REALISATIONS 2021 LIMITED - Company Information

Print Friendly Version

HALSA CARE GROUP LIMITED

Company Registration Number:
05149951 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2018

Period of accounts

Start date: 01 January 2018

End date: 31 December 2018

HALSA CARE GROUP LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2018

Balance sheet
Notes

HALSA CARE GROUP LIMITED

Balance sheet

As at 31 December 2018


Notes
2018
18 months to 31 December 2017


£
£
Fixed assets
Intangible assets:   0 0
Tangible assets: 2 627,303 715,945
Investments: 3 3 3
Total fixed assets: 627,306 715,948
Current assets
Stocks: 0 0
Debtors:   549,087 568,571
Cash at bank and in hand: 0 0
Total current assets: 549,087 568,571
Creditors: amounts falling due within one year:   (662,663) (732,899)
Net current assets (liabilities): (113,576) (164,328)
Total assets less current liabilities: 513,730 551,620
Creditors: amounts falling due after more than one year:   (293,890) (344,767)
Provision for liabilities:   0
Total net assets (liabilities): 219,840 206,853
Capital and reserves
Called up share capital: 205 205
Revaluation reserve:4120,000120,000
Profit and loss account: 99,635 86,648
Shareholders funds: 219,840 206,853

The notes form part of these financial statements

HALSA CARE GROUP LIMITED

Balance sheet statements

For the year ending 31 December 2018 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 02 December 2019
and signed on behalf of the board by:

Name: Eamonn Byrne
Status: Director

The notes form part of these financial statements

HALSA CARE GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2018

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

HALSA CARE GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2018

2. Tangible Assets

Total
Cost £
At 01 January 2018 1,935,221
Additions 172,968
At 31 December 2018 2,108,189
Depreciation
At 01 January 2018 1,219,276
Charge for year 261,610
At 31 December 2018 1,480,886
Net book value
At 31 December 2018 627,303
At 31 December 2017 715,945

HALSA CARE GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2018

3. Fixed investments

Investment in subsidiaries

HALSA CARE GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2018

4. Revaluation reserve

2018
£
Balance at 01 January 2018 120,000
Surplus or deficit after revaluation 0
Balance at 31 December 2018 120,000